(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Sphenopalatine Ganglion Neuralgia
Stanford UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Sphenopalatine Ganglion Neuralgia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Newark Beth Israel Medical Center | Phase 3 | B |
Prochlorperazine Newark Beth Israel Medical Center | Phase 3 | B |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →